Ridgewood Investments LLC Gsk PLC Transaction History

Ridgewood Investments LLC

$201 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$42.05 - $47.77 $83,427 - $94,775	-1,984 Reduced 15.88%	10,506 $457,000
Q1 2022 Apr 11, 2022	SELL	$40.23 - $47.74 $835,496 - $991,464	-20,768 Reduced 62.45%	12,490 $544,000
Q4 2021 Jan 18, 2022	BUY	$38.88 - $45.31 $349 - $407	9 Added 0.03%	33,258 $1.47 Million
Q3 2021 Oct 20, 2021	SELL	$38.79 - $43.16 $12,063 - $13,422	-311 Reduced 0.93%	33,249 $1.27 Million
Q2 2021 Jul 22, 2021	BUY	$36.52 - $41.46 $131,581 - $149,380	3,603 Added 12.03%	33,560 $1.34 Million
Q1 2021 Apr 27, 2021	BUY	$34.27 - $40.01 $670,800 - $783,155	19,574 Added 188.52%	29,957 $1.07 Million
Q3 2020 Oct 14, 2020	SELL	$38.11 - $42.99 $54,573 - $61,561	-1,432 Reduced 12.12%	10,383 $391,000
Q2 2020 Aug 10, 2020	BUY	$37.87 - $43.58 $447,434 - $514,897	11,815 New	11,815 $482,000
Q4 2019 Jan 15, 2020	SELL	$42.0 - $48.25 $372,792 - $428,267	-8,876 Closed	0 $0
Q3 2019 Oct 23, 2019	SELL	$40.46 - $43.52 $18,207 - $19,584	-450 Reduced 4.83%	8,876 $379,000
Q2 2019 Jul 12, 2019	BUY	$39.4 - $42.7 $7,328 - $7,942	186 Added 2.04%	9,326 $373,000
Q1 2019 Apr 15, 2019	BUY	$38.57 - $42.69 $37,991 - $42,049	985 Added 12.08%	9,140 $382,000
Q3 2018 Oct 30, 2018	SELL	$39.75 - $42.69 $9,937 - $10,672	-250 Reduced 2.97%	8,155 $328,000
Q2 2018 Aug 09, 2018	BUY	$39.61 - $42.76 $15,844 - $17,104	400 Added 5.0%	8,405 $339,000
Q2 2018 Jul 23, 2018	SELL	$39.61 - $42.76 $18,339 - $19,797	-463 Reduced 5.47%	8,005 $323,000
Q1 2018 Apr 17, 2018	BUY	$36.18 - $40.15 $23,878 - $26,499	660 Added 8.45%	8,468 $331,000
Q4 2017 Jan 12, 2018	BUY	$35.34 - $41.9 $24,667 - $29,246	698 Added 9.82%	7,808 $277,000
Q3 2017 Nov 15, 2017	BUY	$39.44 - $41.55 $280,418 - $295,420	7,110	7,110 $289,000

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $68.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ridgewood Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ridgewood Investments LLC with notifications on news.

Account